Sphenopalatine Ganglion Block to Treat Shoulder Pain After Thoracotomy

Completed · Phase 1

Conditions studied: Ipsilateral Shoulder Pain

In brief

The purpose of this pilot study is to evaluate the utility of sphenopalatine ganglion (SPG) block to manage ipsilateral shoulder pain (ISP) after thoracotomy. This will be an open label preliminary pilot study to determine if SPG block has potential utility to manage ISP in post-thoracotomy patients. The primary outcome variable will be reduction of shoulder pain.

Key facts

Study ID

NCT02733393

Run by

NYU Langone Health

People needed

2

Starts

2015-09-01

Expected to finish

2017-09-05

Last updated by the study team

2017-10-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Any type of open thoracotomy or video-assisted thoracoscopic surgery (VATS)
• Presence of post-operative ISP, VAS>5/10
• American Society of Anesthesiologists Class 1 - 4
• No allergy to lidocaine

You may not qualify if…

• American Society of Anesthesiologists Class 5
• Allergy to lidocaine
• Nasal pathology (e.g., deviated septum)
• Bleeding diathesis
• Any patient who the PI feels will be unable to comply with all protocol related procedures
• Shoulder pain prior to thoracotomy

Where it is running

• New York University Langone Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.